What are Shock Waves?

High Intensity Pressure Waves

Shockwaves are movements of extremely high pressure caused by, for example, an explosion, an earthquake or a plane breaking the sound barrier.

Extracorporeal Shock Wave Therapy (ESWT) is the application of shock waves in medicine.

It is clinically proven that pressure waves, when applied to injured tissues, stimulate metabolic reactions:

  • Reduction of pain felt by nerve fibers
  • Increase of blood circulation in surrounding soft tissues
  • Beginning of healing process triggered by stem cells activation

How it works

Shockwave Therapy using the Swiss DolorClast® method produces non-invasive, high-energy shock waves and delivers them to the tissue via the surface of the skin via a gel medium.

As a result, the therapy activates self-healing processes where pain occurs. To put it simply: better blood circulation and the formation of new blood vessels results in improved metabolism. This in turn activates cell generation and helps dissolve calcium deposits.

The cause of chronic pain may be eliminated even in a short period of time.




Effective treatment for:  Plantar Fasciitis, Achilles Tendinopathy, and arch/heel pain.

Risks and Contraindications

When performed properly, ESWT® with the Swiss DolorClast® has only minimal risks.

Typical device-related nonserious adverse events are:

  • Pain and discomfort during and after treatment (anesthesia is not necessary)
  • Reddening of the skin
  • Petechia
  • Swelling and numbness of the skin over the treatment area

These device-related nonserious adverse events usually disappear within 36h after the treatment.

Accordingly the following contraindications of ESWT® using the Swiss DolorClast® must be considered:

  • Treatment over air-filled tissue (lung, gut)
  • Treatment of pre-ruptured tendons
  • Treatment of pregnant women
  • Treatment of patients under the age of 18 years (except for Osgood-Schlatter disease and muscular dysfunction in children with spastic movement disorders)
  • Treatment of patients with blood-clotting disorders (including local thrombosis)
  • Treatment of patients treated with oral anticoagulations
  • Treatment of tissue with local tumors or local bacterial and/or viral infections
  • Treatment of patients treated with cortisone
Share this post on:
Share on Facebook
Tweet about this on Twitter
Share on LinkedIn